Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Operating Margin (2016 - 2025)

Historic Operating Margin for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to 9.17%.

  • Tandem Diabetes Care's Operating Margin rose 15200.0% to 9.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.48%, marking a year-over-year decrease of 38400.0%. This contributed to the annual value of 10.54% for FY2024, which is 206500.0% up from last year.
  • According to the latest figures from Q3 2025, Tandem Diabetes Care's Operating Margin is 9.17%, which was up 15200.0% from 21.53% recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Operating Margin ranged from a high of 6.07% in Q4 2021 and a low of 75.46% during Q1 2023
  • Over the past 5 years, Tandem Diabetes Care's median Operating Margin value was 10.7% (recorded in 2024), while the average stood at 15.46%.
  • Its Operating Margin has fluctuated over the past 5 years, first plummeted by -667400bps in 2023, then surged by 537200bps in 2024.
  • Tandem Diabetes Care's Operating Margin (Quarter) stood at 6.07% in 2021, then tumbled by -233bps to 8.06% in 2022, then crashed by -121bps to 17.82% in 2023, then surged by 99bps to 0.21% in 2024, then tumbled by -4362bps to 9.17% in 2025.
  • Its Operating Margin stands at 9.17% for Q3 2025, versus 21.53% for Q2 2025 and 51.56% for Q1 2025.